Hims & Hers Health (HIMS) saw its shares surge in the last session with trading volume being higher than average. The latest ...

Me’s privacy policy explicitly allows the transfer or sale of personal information in the event of a bankruptcy. Here’s what ...

The San-Francisco-based DNA-testing company, 23andMe, announced it has filed for bankruptcy protection and that its ...

Stocks rose in morning trading as Wall Street navigates through uncertainty amid a trade war. The S&P 500 jumped 1.1%. It is ...

Me was founded in 2006 as a direct-to-consumer genetics testing specialist and became a publicly traded company in June 2021, ...

Me was once the darling of postbox DNA testing, but after a colossal data breach and months of business turmoil, the company ...

The current thinking is that we need to recognise obesity as a disease, not a lifestyle choice. “The challenge is to educate ...

Humacyte, Inc. (HUMA) ended the recent trading session at $3.32, demonstrating no swing from the preceding day's closing price. The stock's change was less than the S&P 500's daily gain of 1.77%.

Cytokinetics (CYTK) shares rallied 5.4% in the last trading session to close at $45.43. This move can be attributable to notable volume with a higher number of shares being traded than in a typical ...

Coventry City news from CoventryLive as Sky Blues reporter Andy Tuner brings you a round-up of what's happening in and around ...

Stocks are broadly higher in afternoon trading as Wall Street tries to navigate through the uncertainty of a trade war.

Metabolism is largely influenced by genetics, according to Harvard Health Publishing. Therefore, diet and exercise can be ...